^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Burkitt Lymphoma |
| Drug: | cytarabine (DNA synthesis inhibitor, DNA-directed DNAP inhibitor) + methotrexate (THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor) |
| Regimen: | (vincristine + cyclophosphamide + Rituxan (rituximab) + dexamethasone injection + pegylated liposomal doxorubicin) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
AIDS-related B-cell lymphomas: treatment…burkitt lymphoma…suggested regimens…other recommended regimen…R-HyperCVAD rituximab, cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with high-dose methotrexate and cytarabine
